on 9 Apr 2025
Last Applicant/ Owned by
Takeda Pharmaceuticals International AG
Thurgauerstrasse 130CH-8152 Glattpark-Opfikon
CH
Serial Number
2267923 filed on 11th May 2023
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
préparations pharmaceutiques neurologiques pour le traitement du syndrome de dravet et du syndrome de lennox-gastaut.Vienna Information
5 . 3 . 11
Other leavesAutres feuilles
5 . 3 . 13
Stylized leavesFeuilles stylisées
5 . 3 . 16
More than four leaves, scattered leaves, bunches of leaves -- Note: Not including surfaces or backgrounds covered with a repeated figurative element composed of leaves (25.7.25).Plus de quatre feuilles, feuilles éparses, bouquets de feuilles -- Note: Non compris les surfaces ou fonds couverts d'un élément figuratif répété constitué de feuilles (25.7.25).
5 . 3 . 20
Other branches with leaves, with or without fruitAutres rameaux avec feuilles, avec ou sans fruits
5 . 5 . 2
LiliesLys
5 . 5 . 20
Stylized flowersFleurs stylisées
5 . 5 . 21
One flowerUne fleur
12
2267923
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 1st Oct 2024 | Search Recorded |
Submitted for opposition 20 on 1st Oct 2024 | Examiner's First Report |
Submitted for opposition 223 on 1st Oct 2024 | Total Provisional Refusal |
Submitted for opposition 256 on 6th May 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 15th Jan 2024 | Agent Changed |
Submitted for opposition 257 on 6th Jul 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 6th Jul 2023 | Created |
Submitted for opposition 31 on 6th Jul 2023 | Formalized |
Submitted for opposition 228 on 11th May 2023 | International Registration |
Submitted for opposition 30 on 11th May 2023 | Filed |